Han H

No ORCID on file · 36 papers in corpus · active 2013-2026

Study types

  • article 7
  • other 5
  • review 2

Condition tags

  • endometriosis 12
  • infertility 4
  • endometrioma 2
2026
Journal of pharmaceutical analysis ·doi:10.1016/j.jpha.2025.101451

Spinal cord injury (SCI) is a serious neurological system disease. After SCI, a series of cascade reactions can cause irreversible damage, with a high disability rate and mortality rate. The complexity of the pathological mechanism of SCI l…

2026
Science advances ·doi:10.1126/sciadv.ady4767

Sleep disorders and deficiencies can up-regulate pro-inflammatory mediators, but their potential adverse impact on ovarian function remains not fully understood. In this study, we investigated the immunoregulatory mechanisms underlying slee…

2025
Signal transduction and targeted therapy ·doi:10.1038/s41392-025-02530-2

Nab-paclitaxel plus gemcitabine (AG) is the standard first-line chemotherapy for advanced or metastatic pancreatic ductal adenocarcinoma and has limited efficacy. This phase 1b/2 study aimed to evaluate SHR-1701 (an anti-PD-L1/TGF-βRII fusi…

2025
Frontiers in medicine ·doi:10.3389/fmed.2025.1702214

BackgroundIn vitro fertilization-embryo transfer (IVF-ET) is a core assisted reproductive technology (ART) for infertile couples, but poor endometrial receptivity (ER) severely impairs embryo implantation and reduces success rates, imposing…

2025
Animals : an open access journal from MDPI ·doi:10.3390/ani15121712

In sheep production, due to the limitations of breeding conditions, the uteri of ewes are often infected with bacteria, resulting in the failure of embryo implantation or loss, causing huge losses to the sheep industry. Therefore, in this s…

2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1661806

BackgroundPolycystic ovary syndrome (PCOS) is one of the most common reproductive endocrine disorders affecting women of reproductive age. Insulin resistance (IR) is both a hallmark clinical feature and a key contributor to the pathophysiol…

review 2025
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1645711

Mitophagy is a catabolic mechanism that selectively degrades damaged mitochondria and precisely modulates mitochondrial content, thereby maintaining intracellular homeostasis under stress conditions. To date, most reviews on mitophagy have …

article 2024
Molecular and cellular probes ·doi:10.1016/j.mcp.2024.101999

BACKGROUND: Due to the complex pathogenesis of endometriosis, its early screening and development prediction are still challenging problems in the clinic. OBJECTIVES: This study evaluated the significance of miR-375-3p in endometriosis ons…

other 2024
Heliyon ·doi:10.1016/j.heliyon.2024.e34969

PURPOSE: This research focused on meticulously tracking and identifying adverse reactions associated with leuprorelin, a drug prescribed for conditions such as prostate cancer, endometriosis, uterine fibroids, and early-onset puberty. The m…

other 2024
Experimental and therapeutic medicine ·doi:10.3892/etm.2024.12528

[This retracts the article DOI: 10.3892/etm.2020.9453.].

2023
BMC pregnancy and childbirth ·doi:10.1186/s12884-023-05988-6

BackgroundWe aimed to develop an accurate model to predict live birth for patients receiving in vitro fertilization and embryo transfer (IVF-ET) treatment.MethodsThis is a prospective nested case-control study. Women aged between 18 and 38 …

2023
Biological research ·doi:10.1186/s40659-023-00470-1

BackgroundThe decline in the quantity and quality of mitochondria are closely associated with infertility, particularly in advanced maternal age. Transferring autologous mitochondria into the oocytes of infertile females represents an innov…

2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1295412

PurposeThe relationship between dyslipidemia and female reproductive endocrine diseases has been increasingly studied. The use of lipid-lowering drugs in treating various related diseases, including coronary heart disease, may affect female…

2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1270897

BackgroundAge-related fertility decay is a great challenge for clinicians. Growth hormone (GH) supplementation has been studied as an adjuvant since late 1980s. However, it has not come to a consensus on the GH administration due to the amb…

other 2023
Human fertility (Cambridge, England) ·doi:10.1080/14647273.2021.1981551

Subtle distal Fallopian tube abnormalities comprise a group of diseases that are characterised by subtle variations in tubal anatomy. This prospective cohort study investigated the prevalence of subtle distal Fallopian tube abnormalities in…

2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.954428

ObjectiveTo investigate the effect of weight loss on pregnancy outcomes, PCOS related neuronal-reproductive-metabolic hormones and ovarian granulosa cell gene expression profiles in obese PCOS infertile patients undergoing in vitro fertiliz…

2022
Frontiers in medicine ·doi:10.3389/fmed.2022.1070583

Studies have shown that letrozole cotreatment can improve clinical outcomes in high and poor responders in GnRH-antagonist protocol. However, whether letrozole is also beneficial to normal responders is not known. To investigate the clinica…

2022
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/5076306

Polycystic ovary syndrome (PCOS) is a lifelong reproductive endocrine disease, which is the most common cause of anovular infertility. Modern medicine mainly treats infertile patients with PCOS by improving living habits, ovulation inductio…

2022
BMC pharmacology & toxicology ·doi:10.1186/s40360-022-00592-4

BackgroundAs a progesterone receptor antagonist, mifepristone combined with misoprostol is widely used to terminate early pregnancy in clinical practice. It has also been reported that mifepristone may cause cell death in decidual cells and…

2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.722655

This is a retrospective cohort study included 1021 patients underwent a flexible GnRH antagonist IVF protocol from January 2017 to December 2017 to explore the effect of a premature rise in luteinizing hormone (LH) level on the cumulative l…

2021
ACS medicinal chemistry letters ·doi:10.1021/acsmedchemlett.0c00559

SIRT1, a member of the sirtuin family, catalyzes the deacetylation of proteins with the transformation of NAD+ into nicotinamide and 2'-O-acetyl-ADP-ribose. Selective SIRT1/2 inhibitors have potential application in the chemotherapy of colo…

2021
Frontiers in medicine ·doi:10.3389/fmed.2021.683210

"Dual triggering" for final oocyte maturation using a combination of a gonadotropin-releasing hormone agonist (GnRHa) and human chorionic gonadotropin (hCG) can improve clinical outcomes in high responders during in vitro fertilization-intr…

review 2021
Experimental and therapeutic medicine ·doi:10.3892/etm.2020.9453

Endometriosis is a common reproductive disorder in women, with a global prevalence of 10-15%. Long noncoding RNAs (lncRNAs) are critical to gene transcription, cell cycle modulation and immune response. The lncRNA metastasis-associated lung…

2020
G3 (Bethesda, Md.) ·doi:10.1534/g3.120.401701

As a class of transcription regulators, numerous miRNAs have been verified to participate in regulating ovary follicular development in chickens (Gallus gallus). Previously we showed that gga-miR-135a-5p has significant differential express…

article 2019
Case reports in hepatology ·doi:10.1155/2019/4734606

Hepatic endometriosis is a rare form of endometriosis first described by Finkel in 1986. A thorough review of the literature revealed 28 cases of hepatic endometriosis. This unusual condition offers several diagnostic challenges due to its …